The Gilead Advancing Access® program is committed to helping you afford your medication every step of the way.

If you need assistance with co-pays or paying for your medication, Advancing Access is available to help match you to a program that best meets your financial needs based on your particular circumstances and insurance situation and the eligibility criteria for the programs.

Advancing Access may be able to help guide you through the process of understanding the type of insurance you have and alternative coverage if needed.


REQUESTED PATIENT SUPPORT OFFERINGS

Please select patient support offerings
CHECK ALL BOXES THAT APPLY

Benefits Investigation
Help research and verify specific insurance coverage for Gilead medication
Prior Authorization and Appeals Information
Provides information to your doctor if your insurance company requires your doctor to complete a Prior Authorization for your Gilead medication. Provides follow up with health insurers regarding the status of your Prior Authorization request and sends updates on information needed.
Patient Assistance Program (PAP) Eligibility Screening
If you lack insurance coverage and meet the program criteria, you may be eligible to receive Gilead medication free of charge
Co-Pay Coupon Program Enrollment
If you are eligible, Gilead's Co-Pay Coupon may help lower your out-of-pocket costs. Patients enrolled in government prescription drug programs, such as Medicare Part D and Medicaid are not eligible for the co-pay coupon.


To enroll in the Co-pay Coupon Enrollment service, click here and follow the on screen directions or call Advancing Access at 1-800-226-2056

GILEAD MEDICATION PRESCRIBED



PATIENT INFORMATION

* Indicates required field.


M
F


CONTACT AUTHORIZATION

Yes
No


Continue


Privacy Policy

Terms of Use

Contact Advancing Access at 1-800-226-2056

ADVANCING ACCESS, ATRIPLA, COMPLERA, DESCOVY, EMTRIVA, GENVOYA, GILEAD, the GILEAD Logo, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VEMLIDY, and VIREAD are trademarks of Gilead Sciences, Inc., or its related companies.

©2017 Gilead Sciences, Inc. All rights reserved. ADMC0288 11/17